Wave Life Sciences Ltd (WVE) — Capital Reinvestment Ratio

Latest as of March 2023: 0.01x

Wave Life Sciences Ltd (WVE) has a Capital Reinvestment Ratio of 0.01x as of March 2023, meaning it reinvests 0% of its operating cash flow ($85.52 Million) in capital expenditures ($489.00K). See net asset quality index of Wave Life Sciences Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$85.52 Million

USD

Capital Expenditures

$489.00K

USD

Data as of

Mar 2023

Most recent filing

Annual Capital Reinvestment Ratio for Wave Life Sciences Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Wave Life Sciences Ltd from None to None. For live market cap and broader valuation context, see Wave Life Sciences Ltd (WVE) total market value.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow